Prognostic Significance of Surgical-Pathologic N1 Lymph Node Involvement in Non-Small Cell Lung Cancer

Annals of Thoracic Surgery

Volumn 87, Issue 4, 2009, Pages 1014-1022

  Demir, Adalet ^a   Turna, Akif ^a   Kocaturk, Celalettin ^a   Gunluoglu, Mehmet Zeki ^a   Aydogmus, Umit ^a   Urer, Nur ^a   Bedirhan, Mehmet Ali ^a   Gurses, Atilla ^a   Dincer, Seyit Ibrahim ^a  

^a Yedikule Teaching Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; PATHOLOGY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; SURVIVAL RATE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MEDIASTINUM; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 62649105745     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.12.053     Document Type: Article

References (31)

1. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
2. Rusch V.W., Crowley J., Giroux D.J., et al., International Staging Committee, Cancer Research and Biostatistics, Observers to the Committee, Participating Institutions. The IASLC lung cancer staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2 (2007) 603-612
3. Maggi G., Casadio C., Mancuso M., et al. Resection and radical lymphadenectomy for lung cancer: prognostic significance of lymphatic metastases. Int Surg 75 (1990) 17-21
4. Martini N., Burt M.E., Bains M.S., McCormack P.M., Rusch V.W., and Ginsberg R.J. Survival after resection of stage II nonsmall-cell lung cancer. Ann Thorac Surg 54 (1992) 460-466
5. Yano T., Yokoyama H., Inoue T Asoh H., Tayama K., and Ichinose Y. Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. Significance of N1 level: lobar or hilar nodes. J Thorac Cardiovasc Surg 107 (1994) 1398-1402
6. van Velzen E., Snijder R.J., Brutel de la Rivière A., Elbers H.J., and van den Bosch J.M. Type of lymph node involvement influences survival rates in T1N1M0 non-small cell lung carcinoma. Lymph node involvement by direct extension compared with lobar and hilar node metastases. Chest 110 (1996) 1469-1473
7. van Velzen E., Snijder R.J., Brutel de la Rivière A., Elbers H.R., and van den Bosch J.M. Lymph node type as a prognostic factor for survival in T2 N1 M0 nonsmall-cell lung carcinoma. Ann Thorac Surg 63 (1997) 1436-1440
8. van Velzen E., Brutel de la Rivière A., Elbers H.J., Lammers J.W., and van den Bosch J.M. Type of lymph node involvement and survival in pathologic N1 stage III non-small cell lung carcinoma. Ann Thorac Surg 67 (1999) 903-907
9. Sawyer T.E., Bonner J.A., Gould P.M., et al. Factors predicting patterns of recurrence after resection of N1 nonsmall-cell lung carcinoma. Ann Thorac Surg 68 (1999) 1171-1176
10. Riquet M., Manac'h D., Le Pimpec-Barthes F., Dujon A., and Chehab A. Prognostic significance of surgical-pathologic N1 disease in nonsmall-cell carcinoma of the lung. Ann Thorac Surg 67 (1999) 1572-1576
11. Yoshino I., Nakanishi R., Osaki T., et al. Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases. Chest 116 (1999) 144-149
12. Asamura H., Suzuki K., Kondo H., and Tsuchiya R. Where is the boundary between N1 and N2 stations in lung cancer?. Ann Thorac Surg 70 (2000) 1839-1846
13. Tanaka F., Yanagihara K., Otake Y., et al. Prognostic factors in patients with resected pathologic (p-) T1-2N1M0 non-small cell lung cancer (NSCLC). Eur J Cardiothorac Surg 19 (2001) 555-561
14. Marra A., Hillejan L., Zaboura G., Fujimoto T., Greschuchna D., and Stamatis G. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis. J Thorac Cardiovasc Surg 125 (2003) 543-553
15. Nakagawa T., Okumura N., Kokado Y., Miyoshi K., Matsuoka T., and Kameyama K. Retrospective study of patients with pathologic N1-stage II non-small cell lung cancer. Interact Cardiovasc Thorac Surg 6 (2007) 474-478
16. Travis W.D., Colby T.V., Corrin B., Shimosato Y., and Brambilla E. Histological typing of tumours of lung and pleura. In: Sobin L.H. (Ed). World Health Organization international classification of tumours. 3rd ed. (1999), Springer-Verlag, Berlin, Germany
17. Mountain C.F., and Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 111 (1997) 1718-1723
18. Rami-Porta R., Ball D., Crowley J., et al., International Staging Committee, Cancer Research and Biostatistics, Observers to the Committee, Participating Institutions. The IASLC lung cancer staging project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2 (2007) 593-602
19. Goldstraw P., Crowley J., Chansky K., et al., International Association for the Study of Lung Cancer International Staging Committee, Participating Institutions. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2 (2007) 706-714 Erratum in: J Thorac Oncol 2007;2:985.
20. Osaki T., Nagashima A., Yoshimatsu T., Tashima Y., and Yasumoto K. Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer. Lung Cancer 43 (2004) 151-157
21. Rea F., Marulli G., Callegaro D., et al. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?. Lung Cancer 45 (2004) 215-220
22. Sayar A., Turna A., Kiliçgün A., Solak O., Urer N., and Gürses A. Prognostic significance of surgical-pathologic multiple-station N1 disease in non-small cell carcinoma of the lung. Eur J Cardiothorac Surg 25 (2004) 434-438
23. Watanabe S., Ladas G., and Golstraw P. Inter-observer variability in systematic nodal dissection: comparison of European and Japanese nodal designation. Surgery 73 (2002) 245-248
24. Naruke T., Suemasu K., and Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 76 (1978) 833-839
25. The Japan Lung Cancer Society. Classification of lung cancer. 1st English ed. (2000), Kanehara & Co, Tokyo
26. Korst R.J., and Ginsberg R.J. Appropriate surgical treatment of resectable non-small-cell lung cancer. World J Surg 25 (2001) 184-188
27. Murray G.F., Mendes O.C., and Wilcox B.R. Bronchial carcinoma and the lymphatic sump: the importance of bronchoscopic findings. Ann Thorac Surg 34 (1982) 634-639
28. Okada M., Yamagishi H., Satake S., et al. Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy. J Thorac Cardiovasc Surg 119 (2000) 814-819
29. Martin-Ucar A.E., Chaudhuri N., Edwards J.G., and Waller D.A. Can pneumonectomy for non-small cell lung cancer be avoided?. An audit of parenchymal sparing lung surgery. Eur J Cardiothorac Surg 21 (2002) 601-605
30. Fukai R., Sakao Y., Sakuraba M., et al. The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung. Eur J Cardiothorac Surg 32 (2007) 440-444
31. Khan O.A., Fitzgerald J.J., Field M.L., et al. Histological determinants of survival in completely resected T1-2N1M0 non-small cell cancer of the lung. Ann Thorac Surg 77 (2004) 1173-1178